Stock UniverseDerived research view · source repositories remain read-only

Royalty Pharma plc (RPRX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
38.62
Global Rank
593
Market Cap
26.66B
Latest Close
55.87
RS Composite
22.06% · G#415

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
10.64%
3M
23.58%
6M
42.45%
1Y
70.66%
3Y
84.73%
5Y
56.58%
10Y
43.34%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 5.80M · 30-day average: 4.22M · Max drawdown over stored range: -49.68%

Research Snapshot

Relative Strength vs SPX

RS Composite22.06%
20D RS11.15%
60D RS11.22%
120D RS38.36%
Global RS Rank415 · 87.63% percentile
Qualified+ RS Rank167 · 86.72% percentile
Group ScopeQualified+
Primary RS Rank65 · 85.81% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank75 / 701
Primary Percentile89.44
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-062.44Bn/a1.59B827.29M1.484.17Bn/an/a559Mn/a65.08%33.90%1.71%n/a586.39M8.58B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$1.4837.8x$4.3712.8xn/an/a$7.467.5x

Shares Diluted: 559M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue2289.4632237.2152354.5542263.5762378.193
Revenue Growth (YoY)7.874%-2.282%5.245%-3.864%5.064%
Gross Profit1836.6211332.9711793.8981531.1152674.031
Operating Income1430.715922.8921492.151292.4441559.518
Free Cash Flow2017.5362143.982987.8022768.9862489.823
Free Cash Flow Per Share4.8638531154623174.8952444448503564.95571736606402354.6607451843772524.411021250586849
EPS (Diluted) GAAP1.490.0977982.5336871.9119011.781403
EPS Growth12.967%-93.436%2490.735%-24.541%-6.826%
EPS Non-GAAP
Gross Margin80.221%59.582%76.188%67.641%112.44%
Operating Margin62.491%41.252%63.373%57.097%65.576%
Profit Margin27.069%1.915%48.197%37.948%32.417%
Free Cash Flow Margin88.1227%95.8325%126.8946%122.3279%104.6939%
Shares Outstanding (Diluted)414.802437.972602.9594.108564.455
Shares Change (YoY)10.48%5.586%37.657%-1.458%-4.991%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-06630.58Mn/a563.04M89.29%294.69M46.73%0.67556.84M586.39M8.58Bprocessed
2025 Q42026-02-11621.99Mn/a388.38M62.44%214.21M34.44%0.38557.56M618.70M8.57Bprocessed
2025 Q32025-11-05609.29Mn/a427.16M70.11%288.22M47.30%0.67559.61M938.94M8.57Bprocessed
2025 Q22025-08-06578.66Mn/a209.80M36.26%30.18M5.21%0.07562.30M631.91M7.00Bprocessed
2025 Q12025-05-08568.25Mn/a534.18M94.01%238.35M41.94%0.55578.10M1.09B6.62Bprocessed
2024 Q42025-02-12593.64Mn/a361.51M60.90%208.21M35.07%0.35589.38M929.03M6.61Bprocessed
2024 Q32024-11-06564.69Mn/a735.07M1.30%543.99M96.33%1.21592.73M950.05M6.61Bprocessed
2024 Q22024-08-08537.27Mn/a269.63M50.19%102.00M18.99%0.23596.91M1.76B7.60Bprocessed
2024 Q12024-05-09567.98Mn/a-73.77M-12.99%4.78M0.84%0.01597.48M843.00M6.14Bprocessed
2023 Q42024-02-15596.07Mn/a612.90M1.03%494.34M82.93%0.83597.45M477.01M6.14Bprocessed
2023 Q32023-11-08536.31Mn/a151.44M28.24%72.11M13.45%0.16601.14M936.45M6.13Bprocessed
2023 Q22023-08-08538.20Mn/a248.84M46.24%227.62M42.29%0.50605.86M2.17B6.13Bprocessed
2023 Q12023-05-09683.97Mn/a478.97M70.03%340.75M49.82%0.76607.25M1.98B6.12Bprocessed
2022 Q42023-02-15565.75Mn/a-482.65M-85.31%-456.08M-80.62%6.54-69.74M1.71B6.12Bprocessed
2022 Q32022-11-08573.46Mn/a192.21M33.52%142.65M24.88%0.32607.23M991.63M6.11Bprocessed
2022 Q22022-08-04535.96Mn/a377.79M70.49%304.50M56.82%0.70607.21M2.11B7.11Bprocessed
2022 Q12022-05-05562.05Mn/a219.72M39.09%51.76M9.21%0.12607.20M1.79B7.10Bprocessed
2021 Q42022-02-15575.70Mn/a153.42M26.65%7.90M1.37%-0.05-162.25M1.54B7.10Bprocessed
2021 Q32021-11-10585.77Mn/a303.05M51.74%101.93M17.40%0.24607.17M1.80B7.09Bprocessed
2021 Q22021-08-11554.96Mn/a744.95M1.34%440.78M79.42%1.08607.16M1.14B5.83Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.